Role of Bodhi Satva Sukshma Aushadhi in increasing attention span of children affected with Attention Deficit Hyperactivity Disorder (ADHD).

A randomised single blind placebo controlled comparative clinical study to evaluate the efficacy of Bodhi Satva Sukshma Aushadhi in the management of Attention Deficit Hyperactivity Disorder in children. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069890

Enrollment

Registered

2024-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged between 5-12 years of age 2. Children having signs and clinically diagnosed for Attention Deficit Hyperactivity Disorder ADHD as per DSM-5 Criteria.

Exclusion criteria

Exclusion criteria: 1. Children not fulfilling the DSM-5 Criteria for diagnosis of Attention Deficit Hyperactivity Disorder ADHD. 2. Known case of Cerebral palsy, mental retardation and epilepsy. 3. Known case of hearing deficit. 4. Children with obvious congenital anomalies like Cleft Palate, Coronary Heart Disease. 5. Known case of major systemic disorders and metabolic disorders.

Design outcomes

Primary

Measure	Time frame
Reduced DSM-5 ScoreTimepoint: After every 15 Days (From 0th, 15th, 30th, 45th and 60th day).	—

Secondary

Measure	Time frame
Reduced Inattention, Hyperactivity and ImpulsivityTimepoint: After every 15 Days (From 0th, 15th, 30th, 45th and 60th day).	—

Countries

India

Contacts

Public ContactDr Kalpana Dattatray Dhuri

D.Y.Patil Deemed to be University, School of Ayurveda, Nerul, Navi Mumbai

kalpana.dhuri@dypatil.edu9321835616

Outcome results